Rothschild Investment LLC’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.17K Buy
292
+124
+74% +$3.49K ﹤0.01% 2006
2026
Q1
$4.79K Buy
168
+39
+30% +$1.33K ﹤0.01% 2075
2025
Q4
$5.1K Buy
129
+4
+3% +$147 ﹤0.01% 1867
2025
Q3
$4.41K Sell
125
-20
-14% -$689 ﹤0.01% 1763
2025
Q2
$4.75K Sell
145
-5
-3% -$162 ﹤0.01% 1536
2025
Q1
$4.84K Buy
150
+45
+43% +$1.67K ﹤0.01% 1449
2024
Q4
$3.21K Buy
105
+40
+62% +$1.29K ﹤0.01% 1538
2024
Q3
$1.82K Buy
65
+40
+160% +$986 ﹤0.01% 1777
2024
Q2
$569 Buy
25
+20
+400% +$462 ﹤0.01% 1934
2024
Q1
$152 Buy
+5
New +$167 ﹤0.01% 1891

Other funds holding ATRC

Rothschild Investment LLC's ATRC Position: Q2 2026 in Review

Rothschild Investment LLC increased its AtriCure (ATRC) stake by 74% in Q2 2026, buying an estimated $3.49K and bringing the position to 292 shares worth $8.17K. The position accounts for ﹤0.01% of the portfolio, ranked #2006.

Rothschild Investment LLC first reported a position in ATRC in Q1 2024 and has held it in 10 quarters since. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Rothschild Investment LLC held 292 shares of AtriCure worth $8.17K as of Q2 2026.
  • Rothschild Investment LLC bought 124 AtriCure shares in Q2 2026, an estimated $3.49K.
  • AtriCure made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2006 holding.
  • Rothschild Investment LLC first reported a position in AtriCure in Q1 2024 and has held it in 10 quarters since.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.